A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-11-26
DOI
10.3389/fphar.2018.01365
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PTL401, a New Formulation Based on Pro-Nano Dispersion Technology, Improves Oral Cannabinoids Bioavailability in Healthy Volunteers
- (2018) Jacob Atsmon et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
- (2018) Elizabeth A Thiele et al. LANCET
- Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome
- (2018) Orrin Devinsky et al. NEUROLOGY
- Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome
- (2018) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interactions between cannabidiol and commonly used antiepileptic drugs
- (2017) Tyler E. Gaston et al. EPILEPSIA
- The effect of Pro NanoLipospheres (PNL) formulation containing natural absorption enhancers on the oral bioavailability of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in a rat model
- (2017) Irina Cherniakov et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Piperine-pro-nanolipospheres as a novel oral delivery system of cannabinoids: Pharmacokinetic evaluation in healthy volunteers in comparison to buccal spray administration
- (2017) Irina Cherniakov et al. JOURNAL OF CONTROLLED RELEASE
- High-Dose Cannabidiol Induced Hypotension after Global Hypoxia-Ischemia in Piglets
- (2017) Håvard T. Garberg et al. Neonatology
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration
- (2016) Madeleine J. Swortwood et al. Drug Testing and Analysis
- Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy
- (2015) Alexandra L. Geffrey et al. EPILEPSIA
- Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis
- (2015) D.C. Hammell et al. EUROPEAN JOURNAL OF PAIN
- Safety and Pharmacokinetics of Oral Cannabidiol When Administered Concomitantly With Intravenous Fentanyl in Humans
- (2015) Alex F. Manini et al. Journal of Addiction Medicine
- Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis
- (2015) Margaret Haney et al. NEUROPSYCHOPHARMACOLOGY
- A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis
- (2015) Sabrina Giacoppo et al. DARU-Journal of Pharmaceutical Sciences
- Phase I and II Cannabinoid Disposition in Blood and Plasma of Occasional and Frequent Smokers Following Controlled Smoked Cannabis
- (2014) N. A. Desrosiers et al. CLINICAL CHEMISTRY
- Cannabinoid disposition in oral fluid after controlled cannabis smoking in frequent and occasional smokers
- (2014) Matthew N. Newmeyer et al. Drug Testing and Analysis
- Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial
- (2014) Marcos Hortes N Chagas et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2013) David Moher ANNALS OF INTERNAL MEDICINE
- Effect of a High-Calorie, High-Fat Meal on the Bioavailability and Pharmacokinetics of PA-824 in Healthy Adult Subjects
- (2013) Helen Winter et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cannabidiol Is a Potent Inhibitor of the Catalytic Activity of Cytochrome P450 2C19
- (2013) Rongrong Jiang et al. Drug Metabolism and Pharmacokinetics
- Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review
- (2013) Stephen M. Stout et al. DRUG METABOLISM REVIEWS
- A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of Rifampicin, Ketoconazole, and Omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers
- (2013) Colin Stott et al. SpringerPlus
- Cannabinoid Disposition in Oral Fluid after Controlled Smoked Cannabis
- (2012) D. Lee et al. CLINICAL CHEMISTRY
- A phase I study to assess the effect of food on the single dose bioavailability of the THC/CBD oromucosal spray
- (2012) C. G. Stott et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- A phase I study to assess the single and multiple dose pharmacokinetics of THC/CBD oromucosal spray
- (2012) C. G. Stott et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Heat Exposure ofCannabis sativaExtracts Affects the Pharmacokinetic and Metabolic Profile in Healthy Male Subjects
- (2012) Martin Eichler et al. PLANTA MEDICA
- Distinct Neurobehavioural Effects of Cannabidiol in Transmembrane Domain Neuregulin 1 Mutant Mice
- (2012) Leonora E. Long et al. PLoS One
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Identification of Recent Cannabis Use: Whole-Blood and Plasma Free and Glucuronidated Cannabinoid Pharmacokinetics following Controlled Smoked Cannabis Administration
- (2011) D. M. Schwope et al. CLINICAL CHEMISTRY
- Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive–compulsive behaviour
- (2011) Serena Deiana et al. PSYCHOPHARMACOLOGY
- Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and Adults
- (2011) Eva Fernandez et al. Pharmaceutics
- How important are sex differences in cannabinoid action?
- (2010) Liana Fattore et al. BRITISH JOURNAL OF PHARMACOLOGY
- Plasma Cannabinoid Pharmacokinetics following Controlled Oral 9-Tetrahydrocannabinol and Oromucosal Cannabis Extract Administration
- (2010) E. L. Karschner et al. CLINICAL CHEMISTRY
- Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
- (2010) José Alexandre S Crippa et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Reintoxication: the release of fat-stored Δ9-tetrahydrocannabinol (THC) into blood is enhanced by food deprivation or ACTH exposure
- (2009) N Gunasekaran et al. BRITISH JOURNAL OF PHARMACOLOGY
- Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
- (2009) Angelo A. Izzo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started